Pomerantz LLP is investigating potential securities fraud claims on behalf of investors in Albertsons Companies, Inc. (NYSE: ACI), triggered by a sharp 21.63% decline in the company’s share price on July 23, 2025. The probe examines whether Albertsons and certain officers or directors engaged in unlawful business practices during the relevant period, following disappointing first-quarter results that missed consensus estimates. This investigation signals significant legal risk for the retailer, as shareholders seek to recover losses stemming from alleged misrepresentations regarding the company’s financial health and future outlook.

The catalyst for the inquiry was Albertsons’ financial report for the first quarter of 2026, released on July 23, 2026. The company posted adjusted earnings per share (EPS) of $0.42, which fell short of analyst expectations. Compounding the negative sentiment, management simultaneously lowered its full-year 2026 EPS outlook. In response to these disclosures, Albertsons’ stock price plummeted by $3.11 per share, closing at $11.27 per share on July 23, 2025. The severity of this single-day erosion of shareholder value has prompted the law firm to assess whether material misstatements or omissions occurred prior to the announcement.

Investigation Details

Pomerantz LLP, headquartered in New York with additional offices in Chicago, Los Angeles, London, Paris, and Tel Aviv, is a premier firm specializing in corporate, securities, and antitrust class litigation. Founded by Abraham L. Pomerantz, widely recognized as the dean of the class action bar, the firm pioneered the field of securities class actions. For over 85 years, Pomerantz has secured multimillion-dollar damages awards for class members alleging securities fraud, breaches of fiduciary duty, and corporate misconduct. The firm emphasizes that prior results do not guarantee similar outcomes in current proceedings.

Investors who purchased Albertsons shares are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980, to discuss their rights and potential participation in the class action. The firm’s investigation focuses on determining if the company’s public statements leading up to the earnings release were misleading or lacked a reasonable basis.

Key Financial Metrics

What the Numbers Show

The magnitude of the market reaction—a 21.63% single-day decline—indicates that investors interpreted the combination of the EPS miss and the reduced full-year guidance as a critical failure in management’s forecasting or operational execution. The drop to $11.27 per share represents a substantial immediate loss of equity value, highlighting the market’s sensitivity to Albertsons’ profitability trajectory. The investigation will likely scrutinize whether the company had internal knowledge of these deteriorating trends before publicly affirming its previous outlook, potentially exposing executives to liability for failing to disclose material adverse information in a timely manner.

Albertsons Companies Inc. is facing intensified legal scrutiny from two securities litigation firms after its shares plunged approximately 22% on July 23, 2026. The market reaction followed the retailer’s first-quarter earnings miss and a sharp reduction in its full-year adjusted earnings per share (EPS) guidance. Levi & Korsinsky and Schall, Brown & Schwartz LLP (SBS) are independently investigating whether the company issued misleading statements or failed to disclose material information regarding its financial health prior to the decline.

Investigation Scope

Levi & Korsinsky’s review focuses on the divergence between Albertsons’ April 14, 2026 outlook and the July 23 update. On April 14, CFO Sharon McCollam projected FY26 adjusted EPS would be in the range of $2.22 to $2.32, citing approximately $600 million in share repurchases. CEO Susan Morris stated the company was entering fiscal 2026 with "confidence, clarity and momentum." By July 23, the company cut this guidance to a range of $1.75 to $1.85, representing a roughly 20% reduction at the midpoint. The firm is examining whether earlier statements obscured underlying weaknesses related to pharmacy reimbursement pressure, the Inflation Reduction Act, and macroeconomic uncertainty, all of which were identified as material risks in the April 27, 2026 Form 10-K.

SBS is conducting a parallel investigation into potential securities law violations connected to the same earnings release. Both firms are assessing whether investors suffered losses due to inaccurate financial reporting or omitted material facts. The revised guidance also came in below the $2.27 consensus estimate.

Key Financial Metrics

Albertsons reported Q1 FY26 adjusted EPS of $0.42, missing the consensus estimate of $0.54. The simultaneous guidance cut triggered immediate selling pressure, with shares dropping between 14% and 18% in initial trading before settling at a 22% loss for the day.

What the Numbers Show

The discrepancy between the reported "Net sales and other revenue" of $83,172.50 million in the Form 10-K and the known consolidated revenue of approximately $24.94 billion suggests a significant accounting classification issue. This gap implies that a substantial portion of the top-line figures may not represent core operational revenue, potentially inflating perceived sales volume. Combined with the EPS miss and guidance cut, these figures raise questions about the sustainability of Albertsons’ reported growth metrics prior to July 23.

Investor Eligibility

Investors who purchased Albertsons stock or securities and suffered financial losses may be eligible to participate in either investigation. Eligibility is determined by purchase date and documented losses, regardless of whether shares are still held. There is no minimum loss amount required, and investigations are handled on a contingency basis. Affected shareholders are advised to gather brokerage statements showing purchase dates, share quantities, prices paid, and any subsequent sale details before contacting Levi & Korsinsky or SBS.